Tuesday, December 03, 2019 11:20:26 AM
Looks like a lot of people got whipsawed.
Now they are looking to get back their positions.
Hanging tight on this stock seems to be a good strategy.
The science is cutting edge. A buyout is in the calendar but then a secondary changes that. imo.
A secondary was also a way for the shorts to escape.
Now they are looking to get back their positions.
Hanging tight on this stock seems to be a good strategy.
The science is cutting edge. A buyout is in the calendar but then a secondary changes that. imo.
A secondary was also a way for the shorts to escape.
Recent ARWR News
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/19/2026 08:46:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 11:05:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:35:16 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (US) • 05/12/2026 12:30:00 PM
- Wall Street's Cardiac Bet: Where Diagnostics Meet the Money • PR Newswire (Canada) • 05/12/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 09:27:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:02:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 10:44:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/23/2026 08:44:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/22/2026 09:16:20 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:00:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:49:43 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • InvestorsHub NewsWire • 02/17/2026 02:00:00 PM
- Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/05/2026 09:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:05:15 PM
- Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 • PR Newswire (US) • 02/04/2026 11:15:00 PM
